General Information of the Compound
Compound ID
CP0922327
Compound Name
(3-Bromo-phenyl)-[1-(3-morpholin-4-yl-propyl)-1H-pyrazolo[4,3-g]quinazolin-5-yl]-amine
    Show/Hide
Structure
Formula
C22H23BrN6O
Molecular Weight
467.371
Canonical SMILES
Brc1cccc(Nc2ncnc3cc4c(cnn4CCCN4CCOCC4)cc23)c1
    Show/Hide
InChI
InChI=1S/C22H23BrN6O/c23-17-3-1-4-18(12-17)27-22-19-11-16-14-26-29(21(16)13-20(19)24-15-25-22)6-2-5-28-7-9-30-10-8-28/h1,3-4,11-15H,2,5-10H2,(H,24,25,27)
    Show/Hide
InChIKey
JZIOODYWXRIKDF-UHFFFAOYSA-N
Physicochemical Property
logP
4.2079
Rotatable Bonds
6
Heavy Atom Count
30
Polar Areas
68.1
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44285249
ChEMBL ID
CHEMBL39355
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 77 nM
   TI
   LI
   LO
   TS